These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14575403)

  • 1. Placebo-controlled, randomized, double-blind study evaluating the efficacy of fluticasone propionate nasal spray for the treatment of patients with hyposmia/anosmia.
    Blomqvist EH; Lundblad L; Bergstedt H; Stjärne P
    Acta Otolaryngol; 2003 Sep; 123(7):862-8. PubMed ID: 14575403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relief of sinus pain and pressure with fluticasone propionate aqueous nasal spray: a placebo-controlled trial in patients with allergic rhinitis.
    Ratner PH; Howland WC; Jacobs RL; Reed KD; Goode-Sellers ST; Prillaman BA; Philpot EE; Cook CK
    Allergy Asthma Proc; 2002; 23(4):259-63. PubMed ID: 12221896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical corticosteroids applied with a squirt system are more effective than a nasal spray for steroid-dependent olfactory impairment.
    Shu CH; Lee PL; Shiao AS; Chen KT; Lan MY
    Laryngoscope; 2012 Apr; 122(4):747-50. PubMed ID: 22302665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluticasone propionate nasal spray is more effective and has a faster onset of action than placebo in treatment of rhinitis medicamentosa.
    Hallén H; Enerdal J; Graf P
    Clin Exp Allergy; 1997 May; 27(5):552-8. PubMed ID: 9179430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluticasone propionate: an effective alternative treatment for seasonal allergic rhinitis in adults and adolescents.
    LaForce CF; Dockhorn RJ; Findlay SR; Meltzer EO; Nathan RA; Stricker W; Weakley S; Field EA; Rogenes PR
    J Fam Pract; 1994 Feb; 38(2):145-52. PubMed ID: 8308505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.
    Busse W; Wolfe J; Storms W; Srebro S; Edwards L; Johnson M; Bowers BW; Rogenes PR; Rickard K
    J Fam Pract; 2001 Jul; 50(7):595-602. PubMed ID: 11485708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluticasone propionate improves quality of life in patients with asthma requiring oral corticosteroids.
    Okamoto LJ; Noonan M; DeBoisblanc BP; Kellerman DJ
    Ann Allergy Asthma Immunol; 1996 May; 76(5):455-61. PubMed ID: 8630720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis.
    Banov CH; Woehler TR; LaForce CF; Pearlman DS; Blumenthal MN; Morgan WF; Frazer H; Southern DL; Gold B; Field E
    Ann Allergy; 1994 Sep; 73(3):240-6. PubMed ID: 8092559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study.
    Meltzer EO; Andrews C; Journeay GE; Lim J; Prillaman BA; Garris C; Philpot E
    Ann Allergy Asthma Immunol; 2010 Apr; 104(4):331-8. PubMed ID: 20408344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
    Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR
    Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onset of therapeutic effect of fluticasone propionate aqueous nasal spray.
    Meltzer EO; Rickard KA; Westlund RE; Cook CK
    Ann Allergy Asthma Immunol; 2001 Mar; 86(3):286-91. PubMed ID: 11289326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.
    Paggiaro PL; Dahle R; Bakran I; Frith L; Hollingworth K; Efthimiou J
    Lancet; 1998 Mar; 351(9105):773-80. PubMed ID: 9519948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophil markers in seasonal allergic rhinitis. Intranasal fluticasone propionate inhibits local and systemic increases during the pollen season.
    Nielsen LP; Bjerke T; Christensen MB; Skamling M; Peterson CG; Mygind N; Dahl R
    Allergy; 1998 Aug; 53(8):778-85. PubMed ID: 9722227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of topical nasal fluticasone on objective sleep testing and the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis.
    Craig TJ; Mende C; Hughes K; Kakumanu S; Lehman EB; Chinchilli V
    Allergy Asthma Proc; 2003; 24(1):53-8. PubMed ID: 12635578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
    Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
    Carr WW; Ratner P; Munzel U; Murray R; Price D; Canonica GW; Mullol J; Virchow JC; Lieberman P; Meltzer E; Bachert C
    Allergy Asthma Proc; 2012; 33(6):450-8. PubMed ID: 23127291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis.
    Ratner PH; van Bavel JH; Martin BG; Hampel FC; Howland WC; Rogenes PR; Westlund RE; Bowers BW; Cook CK
    J Fam Pract; 1998 Aug; 47(2):118-25. PubMed ID: 9722799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do corticosteroids induce apoptosis in nasal polyp inflammatory cells? In vivo and in vitro studies.
    Saunders MW; Wheatley AH; George SJ; Lai T; Birchall MA
    Laryngoscope; 1999 May; 109(5):785-90. PubMed ID: 10334231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in nasal reactivity in patients with rhinitis medicamentosa after treatment with fluticasone propionate and placebo nasal spray.
    Graf PM; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1998; 60(6):334-8. PubMed ID: 9742282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.